硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 IgG1 磁珠
蛋白与多肽

抗人 IgG1 磁珠

02AB00053

Human IgG1 is the most abundant subclass of IgG antibodies, representing 60-70% of total IgG in human serum. IgG1 has a flexible structure with a longer hinge region compared to other IgG subclasses, allowing for greater mobility of the Fab fragments relative to the Fc region. This flexibility affects IgG1's ability to bind and activate the classical complement pathway through C1q, as well as its binding to Fc receptors (FcγR) on phagocytic cells to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and phagocytosis. Deficiencies or abnormalities in IgG1 levels or function have been associated with various disease states. IgG1 deficiency is often linked to hypogammaglobulinemia, as IgG1 makes up the majority of total IgG, and low IgG1 levels can lead to increased susceptibility to viral infections. Conversely, excessive or dysregulated IgG1 responses have been implicated in autoimmune diseases and allergic disorders.

Human
规格起售价
登录后可查看

技术参数

宿主
Rat
靶点基因名
IGHG1
蛋白别名
immunoglobulin heavy constant gamma 1 (G1m marker); Human IgG1
UniProt
P01857
物种
Human
应用
IP
Monoclonal
IgG2a

产品详情

靶点名称
Human IgG1
蛋白名称
immunoglobulin heavy constant gamma 1 (G1m marker)
蛋白别名
Immunoglobulin heavy constant gamma 1; Ig gamma-1 chain C region; Ig gamma-1 chain C region EU; Ig gamma-1 chain C region KOL; Ig gamma-1 chain C region NIE
靶点基因名
IGHG1
UniProt
P01857
来源物种
Homo sapiens (Human)
宿主物种
Rat
物种反应性
Human
克隆性
Monoclonal
亚型
IgG2a
配方
Supplied as solution in phosphate buffered saline containing 0.1% BSA and 0.02% sodium azide
剂型
Subject to solid-liquid separation upon standing; Mix thoroughly to ensure a consistent, homogeneous
应用推荐稀释比备注
IP—50-100 μL/200 μg cell lysate

背景介绍

Human IgG1 is the most abundant subclass of IgG antibodies, representing 60-70% of total IgG in human serum. IgG1 has a flexible structure with a longer hinge region compared to other IgG subclasses, allowing for greater mobility of the Fab fragments relative to the Fc region. This flexibility affects IgG1's ability to bind and activate the classical complement pathway through C1q, as well as its binding to Fc receptors (FcγR) on phagocytic cells to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) and phagocytosis. Deficiencies or abnormalities in IgG1 levels or function have been associated with various disease states. IgG1 deficiency is often linked to hypogammaglobulinemia, as IgG1 makes up the majority of total IgG, and low IgG1 levels can lead to increased susceptibility to viral infections. Conversely, excessive or dysregulated IgG1 responses have been implicated in autoimmune diseases and allergic disorders.